Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE5A | O76074 | 18/20 | 0.45 |
| ▸ | PDE1A | P54750 | 3/20 | 0.45 |
| ▸ | PDE1B | Q01064 | 3/20 | 0.45 |
| ▸ | PDE1C | Q14123 | 3/20 | 0.45 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.45 |
| ▸ | PDE2A | O00408 | 1/20 | 0.45 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.45 |
| ▸ | ABCC5 | O15440 | 1/20 | 0.45 |
| ▸ | PDE6D | O43924 | 1/20 | 0.45 |
| ▸ | PDE8A | O60658 | 1/20 | 0.45 |
| ▸ | PDE9A | O76083 | 1/20 | 0.45 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | HTR1A | P08908 | 1/20 | 0.45 |
| ▸ | PDE6A | P16499 | 1/20 | 0.45 |
| ▸ | PDE6G | P18545 | 1/20 | 0.45 |
| ▸ | PDE4A | P27815 | 1/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.45 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.45 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3453681 | 0.91 | PDE5A (0.53) | PDE5APDE1APDE1BPDE1CPDE4B | |
| SCHEMBL7450974 | 0.84 | PDE5A (0.45) | PDE5APDE1APDE1BPDE1CPDE4B | |
| SCHEMBL7449440 | 0.83 | PDE5A (0.56) | PDE5APDE1APDE1BPDE1CPDE4B | |
| SCHEMBL5076135 | 0.82 | PDE5A (0.54) | PDE5APDE1APDE1BPDE1CPDE3B | |
| SCHEMBL5795456 | 0.79 | CA12 (0.59) | PDE5APDE1APDE1BPDE1CPDE4B | |
| SCHEMBL15112594 | 0.77 | PDE5A (0.64) | PDE5APDE1APDE1BPDE1CPDE4B | |
| SCHEMBL7428002 | 0.76 | PDE5A (0.34) | PDE5APDE1APDE1BPDE1CPDE4B | |
| SCHEMBL5201813 | 0.74 | NPSR1 (0.41) | PDE5APDE6CCA12CA9 | |
| SCHEMBL1516 | 0.72 | PDE5A (0.84) | PDE5APDE1APDE1BPDE1CPDE4B | |
| SCHEMBL7782809 | 0.70 | PDE5A (0.55) | PDE5APDE1APDE1BPDE1CPDE3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1418896-A2 | ADMINISTRATION OF PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF PREMATURE EJACULATION | Vivus, Inc. (US) | 2004-05-19 | — | — | EP | claimed |
| WO-2003000343-A2 | ADMINISTRATION OF PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF PREMATURE EJACULATION | VIVUS, INC. (US) | 2003-01-03 | — | — | WO | claimed |
| EP-0702555-A1 | PYRAZOLOPYRIMIDINONES FOR THE TREATMENT OF IMPOTENCE | Pfizer Limited (GB) | 1996-03-27 | — | — | EP | claimed |
| WO-1994028902-A1 | PYRAZOLOPYRIMIDINONES FOR THE TREATMENT OF IMPOTENCE | PFIZER LIMITED (GB) | 1994-12-22 | — | — | WO | claimed |
| EP-1868590-A2 | METHOD OF INCREASING TESTOSTERONE AND RELATED STEROID CONCENTRATIONS IN WOMEN | Unimed Pharmaceuticals, Inc. (US) | 2007-12-26 | — | — | EP | disclosed |
| WO-2006113242-A2 | METHOD OF INCREASING TESTOSTERONE AND RELATED STEROID CONCENTRATIONS IN WOMEN | UNIMED PHARMACEUTICALS, INC. (US) | 2006-10-26 | — | — | WO | disclosed |
| EP-1404343-A4 | THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF HORMONE DEFICIENCIES | SOLVAY PHARMACEUTICALS INC (US) | 2006-08-02 | — | — | EP | disclosed |
| EP-1511494-A1 | ANDROGEN PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING DEPRESSION | Unimed Pharmaceuticals, Inc. (US) | 2005-03-09 | — | — | EP | disclosed |
| WO-2004091631-A1 | ANDROGEN PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING DEPRESSION | UNIMED PHARMACEUTICALS, INC. (US) | 2004-10-28 | — | — | WO | disclosed |
| EP-1418896-A2 | ADMINISTRATION OF PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF PREMATURE EJACULATION | Vivus, Inc. (US) | 2004-05-19 | — | — | EP | disclosed |
| EP-1404343-A2 | THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF HORMONE DEFICIENCIES | Solvay Pharmaceuticals, Inc. (US) | 2004-04-07 | — | — | EP | disclosed |
| WO-2003002123-A2 | THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF HORMONE DEFICIENCIES | SOLVAY PHARMACEUTICALS, INC. (US) | 2003-01-09 | — | — | WO | disclosed |
| WO-2003000343-A2 | ADMINISTRATION OF PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF PREMATURE EJACULATION | VIVUS, INC. (US) | 2003-01-03 | — | — | WO | disclosed |
| EP-1140044-A2 | cGMP PDE 5 INHIBITORS FOR INHALATION IN THE TREATMENT OF SEXUAL DYSFUNCTION | Novartis AG (CH) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000037061-A2 | cGMP PDE 5 INHIBITORS FOR INHALATION IN THE TREATMENT OF SEXUAL DYSFUNCTION | NOVARTIS AG (CH) | 2000-06-29 | — | — | WO | disclosed |
| EP-0702555-A1 | PYRAZOLOPYRIMIDINONES FOR THE TREATMENT OF IMPOTENCE | Pfizer Limited (GB) | 1996-03-27 | — | — | EP | disclosed |
| WO-1994028902-A1 | PYRAZOLOPYRIMIDINONES FOR THE TREATMENT OF IMPOTENCE | PFIZER LIMITED (GB) | 1994-12-22 | — | — | WO | disclosed |